Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Excellos
San Diego, California, United Statesexcellos.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Excellos provides end-to-end cGMP services for the development and manufacture of advanced cell therapies. Their proprietary technologies enable deep immune profiling of donor cells to reduce variability in clinical responses. They have been selected by Galapagos to manufacture the CAR-T candidate GLPG5101 for a Phase 1 trial in relapsed/refractory non-Hodgkin lymphoma using a decentralized manufacturing model with rapid turnaround times. The company’s experience spans TILs, autologous/allogeneic CAR-T/NK/TCR therapies.
- Therapeutic areas
- Oncology
- Modalities
- Cell therapyGene therapyAdoptive cell therapyCAR-T cell therapyNK cell therapyTIL-based therapiesTCR therapy
- Industry
- Contract Manufacturing Organization
02
Partnerships
Galapagos NV (manufacturing partner for GLPG5101/ATALANTA-1 study)San Diego Blood Bank/Blood Centers of America network provides access to donor material and infrastructure support
Beyond the preview
Go deeper on Excellos.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Excellos.